Patel Sapana R, Messner Gabrielle R, Radigan Marleen, Sang Yi, Wang Rui, Gu Gyojeong, Myers Robert W, Dixon Lisa B, Simpson H Blair
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York City (Patel, Messner, Dixon, Simpson); Research Foundation for Mental Hygiene, New York State Psychiatric Institute, New York City (Patel, Dixon, Simpson); New York State Office of Mental Health, Albany (Radigan, Sang, Wang, Gu, Myers).
Psychiatr Serv. 2023 Nov 1;74(11):1185-1188. doi: 10.1176/appi.ps.20220152. Epub 2023 Apr 25.
With a lifetime U.S. prevalence of 2.3%, obsessive-compulsive disorder (OCD) is a chronic condition often producing reduced quality of life and disability when left untreated. Little is known about the prevalence or treatment of diagnosed OCD in public behavioral health systems.
Using a claims analysis of 2019 New York State Medicaid data (N=2,245,084 children; N=4,274,100 adults), the authors investigated the prevalence and characteristics of children and adults with OCD. The authors also examined whether these individuals received treatment with medication or psychotherapy.
The prevalence of OCD was 0.2% among children and 0.3% among adults. Fewer than half of children (40.0%) and adults (37.5%) received U.S. Food and Drug Administration-approved medications (with or without psychotherapy); another 19.4% of children and 11.0% of adults received 45- or 60-minute psychotherapy alone.
These data demonstrate the need for public behavioral health systems to increase their capacity to identify and treat OCD.
在美国，强迫症（OCD）的终生患病率为2.3%，是一种慢性疾病，若不治疗，往往会导致生活质量下降和残疾。关于公共行为健康系统中确诊强迫症的患病率和治疗情况，人们知之甚少。
作者利用对2019年纽约州医疗补助数据的理赔分析（儿童n = 2,245,084；成人n = 4,274,100），调查了患有强迫症的儿童和成人的患病率及特征。作者还研究了这些个体是否接受药物治疗或心理治疗。
儿童强迫症患病率为0.2%，成人患病率为0.3%。不到一半的儿童（40.0%）和成人（37.5%）接受了美国食品药品监督管理局批准的药物治疗（无论是否接受心理治疗）；另有19.4%的儿童和11.0%的成人仅接受了45分钟或60分钟的心理治疗。
这些数据表明，公共行为健康系统需要提高识别和治疗强迫症的能力。
